Incidence of SARS-CoV-2 (COVID-19) -associated pulmonary aspergillosis (CAPA) before and after dexamethasone therapy - a retrospective analysis : Incidence of SARS-CoV-2 (COVID-19) -associated pulmonary aspergillosis (CAPA) before and after dexamethasone therapy - a retrospective analysis - COVID DEXA

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 14. Nov. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: ;B44.0 - Invasive pulmonary aspergillosis
Recruitment Status: Recruiting
Study Type: Observational

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-08-2021, Last updated: 2022-11-24

ICTRP ID:

DRKS00026071
20-9368-BO

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007843062